VANI
Vivani Medical Inc (VANI)
Healthcare • NASDAQ • $1.19-1.65%
- Symbol
- VANI
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $1.19
- Daily Change
- -1.65%
- Market Cap
- $102.62M
- Trailing P/E
- N/A
- Forward P/E
- -3.40
- 52W High
- $1.92
- 52W Low
- $0.92
- Analyst Target
- $4.83
- Dividend Yield
- N/A
- Beta
- 3.37
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes i…
Company websiteResearch VANI on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.